The Protective Role of GMI, an Immunomodulatory Protein From , on 5-Fluorouracil-Induced Oral and Intestinal Mucositis
5-Fluorouracil (5-FU) is used in the treatment of head and neck cancer patients. However, adverse effects experienced such as mucositis and poor appetite may lead to interruption in chemotherapy. The aim of this study is to evaluate the efficacy of GMI, one fungal immunomodulatory protein found in G...
Main Authors: | Che-Hsing Li, Jiunn-Liang Ko, Chu-Chyn Ou, Wea-Lung Lin, Cheng-Chieh Yen, Chih-Ting Hsu, Yu-Ping Hsiao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-03-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/1534735419833795 |
Similar Items
-
Elucidation of the effects and molecular mechanisms of immunomodulatory protein from Ganoderma microsporum (GMI) on targeting oral cancer stemness
by: Tung-Yuan Wang, et al.
Published: (2018) -
Antimicrobial and adjuvant functions of the immunomodulatory protein GMI from Ganoderma microsporum in animals
by: Yao-Hsuan Yu, et al.
Published: (2011) -
Down-regulation of Wnt/β-catenin signaling pathway in lung cancer cells by GMI, an immunomodulatory protein from Ganoderma microsporum
by: Jen-Chieh, Hsu, et al.
Published: (2016) -
Effects of the Three Tryptophan Residues on the Functions of an Immunomodulatory Protein from Ganoderma microsporum, GMI
by: Kai-Lin Hong, et al.
Published: (2017) -
Enhancing of the immune activity of an immunomodulatory protein, GMI, from Ganoderma lucidum, by direct evolution
by: Chian-Wan Lin, et al.
Published: (2008)